Rodríguez Salazar, M. d. C., Franco Molina, M. A., Mendoza Gamboa, E., Martínez Torres, A. C., Zapata Benavides, P., López González, J. S., . . . Rodríguez Padilla, C. (2017). The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
Cita Chicago Style (17a ed.)Rodríguez Salazar, María del Carmen, et al. The Novel Immunomodulator IMMUNEPOTENT CRP Combined with Chemotherapy Agent Increased the Rate of Immunogenic Cell Death and Prevented Melanoma Growth. 2017.
Cita MLA (9a ed.)Rodríguez Salazar, María del Carmen, et al. The Novel Immunomodulator IMMUNEPOTENT CRP Combined with Chemotherapy Agent Increased the Rate of Immunogenic Cell Death and Prevented Melanoma Growth. 2017.